Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Medicalgorithmics S.A. specializes in advanced cardiac monitoring solutions, particularly through its proprietary PocketECG technology, which allows for remote patient monitoring. The company operates primarily in Poland and has been expanding its presence in the U.S. market, leveraging its unique algorithms for enhanced diagnostic accuracy.
Medicalgorithmics generates revenue through the sale of its PocketECG devices and ongoing subscription fees for remote monitoring services. The company benefits from a strong competitive advantage due to its proprietary technology that offers superior diagnostic capabilities compared to traditional monitoring methods.
Adoption rates of PocketECG in U.S. hospitals
Regulatory approvals for new monitoring technologies
Partnerships with healthcare providers
Trends in telehealth and remote patient monitoring
Technological disruption from new entrants in remote monitoring
Regulatory changes affecting medical device approvals
Emergence of alternative cardiac monitoring technologies
Aggressive pricing strategies from larger competitors
Negative operating cash flow may limit growth investments
Potential liquidity issues if revenue growth does not stabilize
moderate - The demand for medical devices is somewhat insulated from economic downturns, but overall healthcare spending can be influenced by GDP growth.
Higher interest rates may increase the cost of capital for Medicalgorithmics, impacting its ability to finance R&D and expansion efforts, potentially leading to lower valuation multiples.
minimal - The company has a manageable debt-to-equity ratio of 0.41, indicating limited reliance on credit.
growth - Investors are likely attracted to the company's high revenue growth potential in a rapidly expanding market.
high - The stock has shown significant price fluctuations, particularly given its recent performance.
